PRESTIGE BIOPHARMA LIMITED KDRPP

PRESTIGE BIOPHARMA LIMITED KDR

13.670KRWD
−440−3,12%
Alla chiusura del 28 feb, 09:05 GMT
KRW
Nessun attività
Visualizza sui grafici
Indietro

Totale patrimonio netto su PRESTIGE BIOPHARMA LIMITED KDR.

Dati annuali
2019
2020
2021
2022
2023
2024
‪0,00‬
‪‪150,00 B‬‬
‪‪300,00 B‬‬
‪‪450,00 B‬‬
‪‪600,00 B‬‬
Periodo
Valore
Variazione
Variazione %
2024
‪‪510,79 B‬‬
‪‪−37,46 B‬‬
‪−6,83‬%
2023
‪‪548,25 B‬‬
+‪‪116,49 B‬‬
+‪26,98‬%
2022
‪‪431,76 B‬‬
‪‪−141,24 B‬‬
‪−24,65‬%
2021
‪‪573,00 B‬‬
+‪‪434,96 B‬‬
+‪315,08‬%
2020
‪‪138,05 B‬‬
+‪‪79,86 B‬‬
+‪137,24‬%
2019
Dati trimestrali
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q1 '25
‪0,00‬
‪‪160,00 B‬‬
‪‪320,00 B‬‬
‪‪480,00 B‬‬
‪‪640,00 B‬‬
Periodo
Valore
Variazione
Variazione %
Q1 '25
‪‪484,14 B‬‬
‪‪−31,81 B‬‬
‪−6,17‬%
Q3 '24
‪‪515,95 B‬‬
+‪‪5,00 B‬‬
+‪0,98‬%
Q2 '24
‪‪510,95 B‬‬
‪‪−30,03 B‬‬
‪−5,55‬%
Q1 '24
‪‪540,98 B‬‬
‪‪−7,27 B‬‬
‪−1,33‬%
Q4 '23
‪‪548,25 B‬‬
‪‪−10,96 B‬‬
‪−1,96‬%
Q3 '23
‪‪559,21 B‬‬
‪‪−67,10 B‬‬
‪−10,71‬%
Q2 '23
‪‪626,31 B‬‬
‪‪−10,76 B‬‬
‪−1,69‬%
Q1 '23
‪‪637,07 B‬‬
+‪‪205,31 B‬‬
+‪47,55‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21